Search hospitals > Florida > Jacksonville
Mayo Clinic in Florida
Claim this profileJacksonville, Florida 32224
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Tumors
Conducts research for Solid Tumors
Conducts research for Lung Cancer
1617 reported clinical trials
133 medical researchers
Summary
Mayo Clinic in Florida is a medical facility located in Jacksonville, Florida. This center is recognized for care of Cancer, Breast Cancer, Tumors, Solid Tumors, Lung Cancer and other specialties. Mayo Clinic in Florida is involved with conducting 1,617 clinical trials across 1,285 conditions. There are 133 research doctors associated with this hospital, such as Steven Attia, MD, Sikander Ailawadhi, Amit Mahipal, MD, and Jeremy Jones, MD.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
HER2 positive
2Breast Cancer
Global LeaderStage IV
ER positive
HER2 negative
Top PIs
Steven Attia, MDMayo Clinic1 year of reported clinical research
Expert in Sarcoma
Studies Tumors
30 reported clinical trials
43 drugs studied
Sikander AilawadhiMayo Clinic in Florida3 years of reported clinical research
Expert in Multiple Myeloma
Expert in Plasma Cell Neoplasms
20 reported clinical trials
28 drugs studied
Amit Mahipal, MDMayo Clinic2 years of reported clinical research
Studies Tumors
Studies Bile Duct Cancer
19 reported clinical trials
36 drugs studied
Jeremy Jones, MDMayo Clinic in Florida1 year of reported clinical research
Studies Colorectal Cancer
Studies Cancer
14 reported clinical trials
24 drugs studied
Clinical Trials running at Mayo Clinic in Florida
Breast Cancer
Gastroesophageal Junction Adenocarcinoma
Lung Cancer
Gastric Cancer
Non-Small Cell Lung Cancer
Squamous Cell Carcinoma
Tumors
Melanoma
Cutaneous Melanoma
Cervical Cancer
Cancer Vaccine + Pembrolizumab
for Advanced Cancers
This phase I trial tests the safety and tolerability of an experimental personalized vaccine when given by itself and with pembrolizumab in treating patients with solid tumor cancers that have spread to other places in the body (advanced). The experimental vaccine is designed target certain proteins (neoantigens) on individuals' tumor cells. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Giving the personalized neoantigen peptide-based vaccine with pembrolizumab may be safe and effective in treating patients with advanced solid tumors.
Recruiting3 awards Phase 1 & 250 criteria
Lasofoxifene and Abemaciclib vs Fulvestrant and Abemaciclib
for Breast Cancer
The goal of this clinical trial is to assess the efficacy, safety and tolerability of the combination of lasofoxifene and abemaciclib compared to fulvestrant and abemaciclib for the treatment of pre- and postmenopausal women and men who have previously received ribociclib or palbociclib-based treatment and have locally advanced or metastatic estrogen receptor positive (ER+)/human epidermal growth factor 2 negative (HER2-) breast cancer with an estrogen receptor 1 (ESR1) mutation. The main question the study aims to answer is: • To compare the efficacy of the combination of lasofoxifene and abemaciclib with that of fulvestrant and abemaciclib Participants will receive either receive 5 mg/d of oral lasofoxifene plus oral abemaciclib 150 mg twice a day or the combination of fulvestrant 500 mg intramuscular (IM) on Days 1, 15, and 29 and then once monthly thereafter plus oral abemaciclib 150 mg twice a day.
Recruiting2 awards Phase 312 criteria
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Mayo Clinic in Florida?
Mayo Clinic in Florida is a medical facility located in Jacksonville, Florida. This center is recognized for care of Cancer, Breast Cancer, Tumors, Solid Tumors, Lung Cancer and other specialties. Mayo Clinic in Florida is involved with conducting 1,617 clinical trials across 1,285 conditions. There are 133 research doctors associated with this hospital, such as Steven Attia, MD, Sikander Ailawadhi, Amit Mahipal, MD, and Jeremy Jones, MD.
Where is Mayo Clinic in Florida located?
**Mayo Clinic Florida**
- **Address:** 4500 San Pablo Road, Jacksonville, FL 32224
- **Directions:** Take I-95 N to exit 353A for US-1 N toward Forsyth St. After 1.6 miles, continue onto San Pablo Rd S. The destination will be on the right.
Who should I call to ask about financial aid or insurance network?
**Mayo Clinic in Florida - Hospital Financial Assistance and Insurance Contact Information**
- **Financial Assistance:**
- **Phone:** 844-217-9591 (Toll-free), Monday - Friday, 8 a.m. - 5 p.m. Eastern time.
- **Mail:** Mayo Clinic Financial Assistance Application (PDF) with supporting documentation to Mayo Clinic RO WE 01 800K-R, 200 First St. SW, Rochester, MN 55905-0001.
- **Insurance Inquiries:**
- **General and Billing Inquiries Phone:** 844-217-9591, Monday - Friday, 8 a.m. - 5 p.m. Eastern time.
- **Prior Authorization Counselor Phone:**
- Arizona: 480-342-5700
- Florida: 904-956-2050
- Rochester: 833-479-5484 (Toll-free)
- **Out-of-Pocket Expense Estimates:**
- Use Mayo Clinic's cost estimator tool online or contact a financial counselor at the Arizona, Florida, or Rochester campuses.
- **International Patients:**
- Additional information for international patients is available on the Mayo Clinic website.
What insurance does Mayo Clinic in Florida accept?
The Mayo Clinic in Florida accepts a wide range of insurance plans, including Medicare, Medicaid, TRICARE, HMOs, disability insurance, motor vehicle insurance, prescription card plans, and workers' compensation. They have arrangements with various health care insurers, but coverage may vary by individual policy. For specific insurance plan information and to confirm in-network status, it is advised to contact the patient's insurance company directly.
What awards or recognition has Mayo Clinic in Florida received?
Mayo Clinic in Florida is renowned for its significant advancements in research, especially in cancer and biotherapeutics, under the leadership of Alfredo Quiñones-Hinojosa, M.D., appointed as the new dean of Research in 2022. It has been honored as an Antimicrobial Stewardship Center of Excellence by the Infectious Diseases Society of America (IDSA). This recognition is for its exemplary antimicrobial stewardship program, meeting the highest standards of the IDSA and the Centers for Disease Control and Prevention.